Testing effectiveness (Phase 2)Ended earlyNCT05886491What this trial is testingGDX012 in Adults With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forLeukemia Takeda 16
Testing effectiveness (Phase 2)Study completedNCT00015860What this trial is testingSTI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic LeukemiaWho this might be right forLeukemia Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00509691What this trial is testingVaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to TherapyWho this might be right forCancer University of Louisville 20
Testing effectiveness (Phase 2)Ended earlyNCT03301597What this trial is testingNLA101 in Adults Receiving High Dose Chemotherapy for AMLWho this might be right forLeukemia, Myeloid, Acute Nohla Therapeutics, Inc. 146
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00036790What this trial is testingMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more University of Wisconsin, Madison
Testing effectiveness (Phase 2)Looking for participantsNCT05031897What this trial is testingTwo Step Haplo With Radiation ConditioningWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAdult T-Cell Leukemia/Lymphoma+14 more Thomas Jefferson University 63
Early research (Phase 1)Study completedNCT01246622What this trial is testingLenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+4 more Roswell Park Cancer Institute 32
Testing effectiveness (Phase 2)Study completedNCT01093573What this trial is testingMidostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous LeukemiaWho this might be right forUntreated Adult Acute Myeloid Leukemia Brenda Cooper, MD 34
Early research (Phase 1)Study completedNCT03125239What this trial is testingCombination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forRelapsed Adult Acute Myeloid LeukemiaRefractory Adult Acute Myeloid Leukemia Jacqueline Garcia, MD 16
Large-scale testing (Phase 3)Study completedNCT00005866What this trial is testingS9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid LeukemiaWho this might be right forLeukemiaMyelodysplastic Syndromes SWOG Cancer Research Network 240
Testing effectiveness (Phase 2)Looking for participantsNCT06022003What this trial is testingStudy Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid LeukemiaWho this might be right forAML, AdultRefractory AMLRelapsed Adult AML+2 more French Innovative Leukemia Organisation 33
Early research (Phase 1)Study completedNCT00005988What this trial is testingBone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous TherapyWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)WithdrawnNCT00003405What this trial is testingCombination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous LeukemiaWho this might be right forLeukemia Rush University Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT00295880What this trial is testingDonor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic CancerWho this might be right forMyeloproliferative DisordersLeukemiaLymphoma+1 more Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Ended earlyNCT02038153What this trial is testingLenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell TransplantWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia in Remission Albert Einstein College of Medicine 3
Large-scale testing (Phase 3)Study completedNCT00265837What this trial is testingLaboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72
Large-scale testing (Phase 3)Looking for participantsNCT05907057What this trial is testingAn Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.Who this might be right forAcute Myeloid Leukemia (AML) Servier Affaires Médicales 245
Early research (Phase 1)Looking for participantsNCT05342584What this trial is testingVenetoclax Plus Intensive Chemotherapy in AML and Advanced MDSWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndromes Montefiore Medical Center 99
Large-scale testing (Phase 3)Study completedNCT04446052What this trial is testingPhase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic LeukemiaWho this might be right forAdult Patients (Over 55) With Acute Non-Lymphocytic Leukemia Eastern Cooperative Oncology Group 362